GSK

We are uniting science, technology and talent to get ahead of disease together.
Our community guidelines:

[GSK @GSK]

#News for #Investors and #Media: Today, we announced that the US FDA and the EMA have granted regulatory designations for one of our therapies for the treatment of VEXAS syndrome.

Learn more: https://t.co/xgPeaQNqKz

[GSK @GSK]

#News for #investors and #media:

We have entered an agreement to acquire clinical-stage precision oncology company Nuvalent, Inc., bringing in multiple lung cancer assets to our existing oncology portfolio.

Find out more: https://t.co/r7yUaG73LP